|
|
Volumn 95, Issue 4, 2003, Pages 255-257
|
|
Multidrug resistance: Can new drugs help chemotherapy score against cancer?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
BIRICODAR;
CARBOPLATIN;
COLCHICINE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
GLYCOPROTEIN P;
MULTIDRUG RESISTANCE PROTEIN 1;
NAVELBINE;
NEW DRUG;
PACLITAXEL;
PROTEIN INHIBITOR;
TARIQUIDAR;
TAXANE DERIVATIVE;
UNCLASSIFIED DRUG;
VALSPODAR;
VINCA ALKALOID;
ZOSUQUIDAR;
ACUTE GRANULOCYTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
CANCER COMBINATION CHEMOTHERAPY;
CELL MEMBRANE PERMEABILITY;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG CLEARANCE;
DRUG MECHANISM;
DRUG PENETRATION;
HUMAN;
KIDNEY CANCER;
LUNG NON SMALL CELL CANCER;
MULTIDRUG RESISTANCE;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SIDE EFFECT;
|
|
EID: 0037453894
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.4.255 Document Type: Note |
|
Times cited : (114)
|
|
References (0)
|